Abstract
Marine microorganisms have proven to be a rich source of natural products with unique structures and novel activities, due to their special living conditions. Macrolactins (MLNs), mostly produced by marine-derived microorganisms, are a group of 24-membered lactone natural products, which exhibit potent antibacterial, antifungal, antiviral, anticancer, anti-inflammatory, anti-angiogenic and other activities. Their extensive biological activities make them potential compounds for drug development. MLNs are biosynthesized via a type I polyketide synthase (PKS) pathway with different tailoring steps, such as epoxidation, glycosylation and acylation. These modification steps provide opportunities to diversify their structures by combinatorial biosynthesis strategies. This review mainly focuses on the newly discovered MLNs in the past five years, including their biological activities and relevant biosynthetic studies.
Similar content being viewed by others
References
Chakraborty K, Thilakan B, Raola VK (2014) Polyketide family of novel antibacterial 7-O-Methyl-5′-hydroxy-3′-heptenoate-macrolactin from seaweed-associated Bacillus subtilis MTCC 10403. J Agric Food Chem 62:12194–12208
Chakraborty K, Thilakan B, Kizhakkekalam VK (2017) Antibacterial aryl-crowned polyketide from Bacillus subtilis associated with seaweed Anthophycus longifolius. J Appl Microbiol 124:108–125
Gustafson K, Roman M, Fenical W (1989) The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J Am Chem Soc 111:7519–7524
He S, Wang H, Wu B, Zhou H, Zhu P, Yang R, Yan X (2013) Response surface methodology optimization of fermentation conditions for rapid and efficient accumulation of macrolactin A by marine Bacillus amyloliquefaciens ESB-2. Molecules 18:408–417
Jaruchoktaweechai C, Suwanborirux K, Tanasupawatt S, Kittakoop P, Menasveta P (2000) New macrolactins from a marine Bacillus sp. sc026. J Nat Prod 63:984–986
Ji YH, Kim DH, Kang JS, Kim CG, Chung SU, Hwang SW, Kang KR (2010) Anti-inflammatory composition containing macrolactin A and a derivative thereof as active ingredients. Patent WO2010134790A2
Ji YH, Kim DH, Kim JA, Kang JS, Chung SU, Hwang SW, Kang KR, Kang YR (2012) Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients. Patent WO2012008674A1
Jiménez C (2018) Marine natural products in medicinal chemistry. ACS Med Chem Lett 9:959–961
Jin J, Choi SH, Lee JE, Joo JD, Kim CY (2017a) Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model. Oncol Lett 13:3767–3773
Jin J, Hwang K, Joo JD, Han JH, Kim CY (2017b) Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma. Oncotarget 9:2140–2147
Jung JW, Kim JM, Kwon MH, Kim DH, Kang HE (2014) Pharmacokinetics of macrolactin A and 7-O-succinyl macrolactin A in mice. Xenobiotica 44:547–554
Kim Y, Singer RA, Carreira EM (1998) Total synthesis of macrolactin A with versatile catalytic, enantioselective dienolate aldol addition reactions. Angew Chem Int Ed 37:1261–1263
Li W, Tang XX, Yan X, Wu Z, Yi ZW, Fang MJ, Su X, Qiu YK (2016) A new macrolactin antibiotic from deep sea-derived bacteria Bacillus subtilis B5. Nat Prod Res 30:2777–2782
Liu Y, Zheng H, Yao TT, Tian L, Li WL (2014a) Characterization of macrolactin gene cluster from Bacillus marinus B-9987 and overexpression of trans-acyl transferase. Chin J Mar Drugs 33:69–75
Liu Y, Zhang H, Zhan GH, Qin W, Tian L, Li WL (2014b) Establishment of an efficient transformation protocol and its application in marine-derived Bacillus strain. Sci China Life Sci 57:627–635
Liu Y, Qin W, Liu Q, Zhang J, Li WL (2016) Genome-wide identification and characterization of macrolide glycosyltransferases from a marine-derived Bacillus strain and their phylogenetic distribution. Environ Microbiol 18:4770–4781
Liu Q, Ren PF, Liu Y, Qin W, Li HY, Li WL (2018) Exploration of the glycosyltransferase bmmgt1 from a marine-derived Bacillus strain as a potential enzyme tool for compound glycol-diversification. J Microbiol Biotech 28:931–937
Lu XL, Xu QZ, Shen YH, Liu XY, Jiao BH, Zhang WD, Ni KY (2008) Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat Prod Res 22:342–347
Marino JP, McClure MS, Holub DP, Comasseto JV, Tucci FC (2002) Stereocontrolled synthesis of (-)-macrolactin A. J Am Chem Soc 124:1664–1668
Mohamad M, Tareq FS, Kim JH, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ (2012) New antimicrobial compounds from a marine-derived Bacillus sp. J Antibiot 66:89–95
Mondol MAM, Tareq FS, Kim JH, Lee MA, Lee HS, Lee YJ, Lee JS, Shin HJ (2011a) Cyclic ether-containing macrolactins, antimicrobial 24-membered isomeric macrolactones from a marine Bacillus sp. J Nat Prod 74:2582–2587
Mondol MAM, Kim JH, Lee HS, Lee YJ, Shin HJ (2011b) Macrolactin W, a new antibacterial macrolide from a marine Bacillus sp. Bioorg Med Chem Lett 21:3832–3835
Muhammad M, Hee S (2014) Antibacterial and antiyeast compounds from marine-derived bacteria. Mar Drugs 12:2913–2921
Nagao T, Adachi K, Sakai M, Nishijima M, Sano H (2001) Novel macrolactins as antibiotic lactones from a marine bacterium. J Antibiot 54:333–339
Nakano MM, Corbell N, Besson J, Zuber P (1992) Isolation and characterization of sfp: a gene that functions in the production of the lipopeptide biosurfactant surfactin in Bacillus subtilis. Mol Gen Genet: MGG 232:313–321
Qin W, Liu Y, Ren PF, Zhang J, Li HY, Tian L, Li WL (2014) Uncovering a glycosyltransferase provides insights into the glycosylation step during macrolactin and bacillaene biosynthesis. ChemBioChem 15:2747–2753
Schneider K, Chen XH, Vater J, Franke P, Nicholson G, Borriss R, Süssmuth RD (2007) Macrolactin is the polyketide biosynthesis product of the pks2 cluster of Bacillus amyloliquefaciens FZB42. J Nat Prod 70:1417–1423
Smith AB III, Ott GR (1998) Total syntheses of (-)-macrolactin A, (+)-macrolactin E, and (-)-macrolactinic acid: an exercise in stille cross-coupling chemistry. J Am Chem Soc 120:3935–3948
Tareq FS, Kim JH, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ (2013) Antimicrobial gageomacrolactins characterized from the fermentation of the marine-derived bacterium Bacillus subtilis under optimum growth conditions. J Agric Food Chem 61:3428–3434
Wang TT, He S, Yan XJ, Zhu P (2014) Macrolactins: antitumor antibiotics as marine drug lead. Curr Org Chem 18:804–811
Wang LS, Wang JF, Liu J, Liu YH (2017) Antitubercular marine natural products. Curr Med Chem 24:1–25
Xue CM, Tian L, Xu MJ, Deng ZW, Lin WH (2008) A new 24-membered lactone and a new polyene δ-lactone from the marine bacterium Bacillus marinus. J Antibiot 61:668–674
Yan X, Zhou YX, Tang XX, Liu XX, Yi ZW, Fang MJ, Wu Z, Jiang FQ, Qiu YK (2016) Macrolactins from marine-derived Bacillus subtilis B5 bacteria as inhibitors of inducible nitric oxide and cytokines expression. Mar Drugs 14:1–8
Yoo J, Zheng C, Lee S, Kwak J, Kim W (2006) Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg Med Chem Lett 16:4889–4892
Zheng CJ, Lee S, Lee CH, Kim WG (2007) Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1. J Nat Prod 70:1632–1635
Acknowledgements
This work was financially supported by the grants from the National Key R&D Program of China (2019YFC0312501) and the National Natural Science Foundation of China (U1706206, 31570032).
Author information
Authors and Affiliations
Contributions
TW, FX and WL reviewed the literatures and wrote the manuscript. The manuscript has been approved by all the authors.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interests.
Animal and human rights statement
No animal and human rights are involved in this article.
Additional information
Edited by Chengchao Chen.
Rights and permissions
About this article
Cite this article
Wu, T., Xiao, F. & Li, W. Macrolactins: biological activity and biosynthesis. Mar Life Sci Technol 3, 62–68 (2021). https://doi.org/10.1007/s42995-020-00068-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42995-020-00068-6